Cargando…

LIM Domain Kinases as Potential Therapeutic Targets for Neurofibromatosis Type 2

Neurofibromatosis Type 2 (NF2) is caused by mutations in the neurofibromatosis 2 (NF2) gene that encodes a tumor suppressor protein called merlin. NF2 is characterized by formation of multiple schwannomas, meningiomas and ependymomas. Merlin loss of function is associated with increased activity of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petrilli, Alejandra, Copik, Alicja, Posadas, Michelle, Chang, Long-Sheng, Welling, D. Bradley, Giovannini, Marco, Fernández-Valle, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016185/ https://www.ncbi.nlm.nih.gov/pubmed/23934191 http://dx.doi.org/10.1038/onc.2013.320

Ejemplares similares

Targeting LIM kinase in cancer and neurofibromatosis
por: Rak, Roni, et al.
Publicado: (2014)

LIM kinases in synaptic plasticity and their potential as therapeutic targets
por: Halász, Éva, et al.
Publicado: (2020)

Ponatinib promotes a G(1) cell-cycle arrest of merlin/NF2-deficient human schwann cells
por: Petrilli, Alejandra M, et al.
Publicado: (2017)

Neurofibromatosis: Molecular Pathogenesis and Natural Compounds as Potential Treatments
por: Amaravathi, Anusha, et al.
Publicado: (2021)

LIM kinases: cofilin and beyond
por: Prunier, Chloé, et al.
Publicado: (2017)

LIM Kinases in Osteosarcoma Development
por: Brion, Régis, et al.
Publicado: (2021)

Analysis of the Drosophila Ajuba LIM protein defines functions for distinct LIM domains
por: Rauskolb, Cordelia, et al.
Publicado: (2022)

The Cytoplasmic LIM Domain Protein Espinas Contributes to Photoreceptor Layer Selection in the Visual System
por: Fernández-Pineda, Alejandra, et al.
Publicado: (2020)

Simultaneous Inhibition of PI3K and PAK in Preclinical Models of Neurofibromatosis Type 2-related Schwannomatosis
por: Fernandez-Valle, Cristina, et al.
Publicado: (2023)

Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1
por: Yi, Fei, et al.
Publicado: (2017)

LIM Kinases, Promising but Reluctant Therapeutic Targets: Chemistry and Preclinical Validation In Vivo
por: Berabez, Rayan, et al.
Publicado: (2022)

Targeting LIM kinases in taxane resistant tumors
por: Prunier, Chloé, et al.
Publicado: (2016)

The Role of LIM Kinase in the Male Urogenital System
por: Park, Juhyun, et al.
Publicado: (2021)

LIM Kinases: From Molecular to Pathological Features
por: Bénédetti, Hélène, et al.
Publicado: (2023)

Protein domain-based prediction of drug/compound–target interactions and experimental validation on LIM kinases
por: Doğan, Tunca, et al.
Publicado: (2021)

New developments in neurofibromatosis type 2 and vestibular schwannoma
por: Ren, Yin, et al.
Publicado: (2020)

LIM-Kinases in Synaptic Plasticity, Memory, and Brain Diseases
por: Ben Zablah, Youssif, et al.
Publicado: (2021)

Four-and-a-half LIM domains proteins are novel regulators of the protein kinase D pathway in cardiac myocytes
por: Stathopoulou, Konstantina, et al.
Publicado: (2014)

A requirement for Lim domain binding protein 1 in erythropoiesis
por: Li, LiQi, et al.
Publicado: (2010)

LIM Homeobox Domain 2 Is Required for Corneal Epithelial Homeostasis
por: Sartaj, Rachel, et al.
Publicado: (2016)

The Roles of the LIM Domain Proteins in Drosophila Cardiac and Hematopoietic Morphogenesis
por: She, Meihua, et al.
Publicado: (2021)

PDZ and LIM Domain-Encoding Genes: Their Role in Cancer Development
por: Jiang, Xinyuan, et al.
Publicado: (2023)

Downregulation of LIM kinase 1 suppresses ocular inflammation and fibrosis
por: Gorovoy, Matvey, et al.
Publicado: (2008)

A role for cofilin and LIM kinase in Listeria-induced phagocytosis
por: Bierne, Hélène, et al.
Publicado: (2001)

The LIM-only protein, LMO4, and the LIM domain-binding protein, LDB1, expression in squamous cell carcinomas of the oral cavity
por: Mizunuma, H, et al.
Publicado: (2003)

Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2
por: Prabhakar, Shilpa, et al.
Publicado: (2022)

Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2
por: Allaway, Robert, et al.
Publicado: (2018)

Requirement of LIM domains for the transient accumulation of paxillin at damaged stress fibres
por: Watanabe-Nakayama, Takahiro, et al.
Publicado: (2013)

PDZ and LIM Domain-Encoding Genes: Molecular Interactions and their Role in Development
por: te Velthuis, Aartjan J. W., et al.
Publicado: (2007)

Damnacanthal, an effective inhibitor of LIM-kinase, inhibits cell migration and invasion
por: Ohashi, Kazumasa, et al.
Publicado: (2014)

Inhibition of LIM kinase reduces contraction and proliferation in bladder smooth muscle
por: Yu, Qingfeng, et al.
Publicado: (2021)

Zyxin and cCRP: two interactive LIM domain proteins associated with the cytoskeleton
Publicado: (1992)

New players in end-protection: LIM-domain proteins associate with the shelterin complex
por: Denchi, Eros Lazzerini
Publicado: (2010)

LIM Domain Only 2 Regulates Endothelial Proliferation, Angiogenesis, and Tissue Regeneration
por: Meng, Shu, et al.
Publicado: (2016)

The adherens junction–associated LIM domain protein Smallish regulates epithelial morphogenesis
por: Beati, Hamze, et al.
Publicado: (2018)

The PET and LIM1-2 domains of testin contribute to intramolecular and homodimeric interactions
por: Sala, Stefano, et al.
Publicado: (2017)

Cooperation of LIM domain‐binding 2 (LDB2) with EGR in the pathogenesis of schizophrenia
por: Ohnishi, Tetsuo, et al.
Publicado: (2021)

Bioinformatic Analysis of Structure and Function of LIM Domains of Human Zyxin Family Proteins
por: Siddiqui, M. Quadir, et al.
Publicado: (2021)

The LIM domain protein nTRIP6 modulates the dynamics of myogenic differentiation
por: Norizadeh Abbariki, Tannaz, et al.
Publicado: (2021)

LIM kinase and Diaphanous cooperate to regulate serum response factor and actin dynamics
por: Geneste, Olivier, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_bq0oh13276n9oc6bpcl62ktns3